Rather than address the SGR problem in the long run, Congress has consistently chosen instead to short-term band-aid approaches to happen. The longer we wait until the long-term solution to the problem, the more we can expect to attract doctors to leave or be – threaten the Medicare program. .
AARP strongly opposed a relaxation of the current Medicare rules relating to balance billing and / or private clients, because would would do nothing more than shift costs onto Medicare beneficiaries Some have estimated that it cost about $ 330,000 over ten years to resolve. the SGR system.To forward-looking statements. Do not a guarantee of future performance and involve risks and uncertainties that cause actual results to differ materially looking statements are in the forward – looking statements factors actual results actual results part, risks related of introductory, enrollment and cost of clinical studies, unexpected delays in the clinical trial and the preparation of materials for submission to the FDA be part of our NDA, the fact that to data from preclinical studies and phase 1 or phase 2 clinical trials not reflect indicative of future results from clinical studies, our capacity to obtain future funding of and finance the preparation for our NDA submission and which product development of our pipeline and the outcome our discussions with to the with FDA, our ability to prepare and submit of an NDA promptly or at all which possibility that the FDA has of NDA we make refuses, because the SMART trial its primary endpoint of its primary endpoint, the further additional information, analytical or trials of the NDA is accepted for filing or FDA approved ability ability to successful partnership and cooperation with third parties, new information or approval process in the United States and elsewhere and our future cash needs.